Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

US Retail Drug Spending Growth Slowing With No New Sovaldis In Sight

Jul 13 2016

• By Cathy Kelly

RollOfDollarswithPills_1200x675

Related Content

U.S. Drug Spending Will Increase 7.6% in 2015, Including PCSK9 Costs – CMS

Jul 28 2015

Rx Spending Growth Won’t Exceed 8% In Coming Years – Express Scripts

Mar 15 2016

Price Concessions By Manufacturers To Payers Rose Sharply In 2015

Apr 14 2016

CMS Wants To Facilitate Value-Based Discounts For HCV Drugs In Medicaid

Nov 06 2015

Medicare Value-Pricing Options Vary Widely In Part B Payment Experiment

Mar 14 2016

Lilly's Performance Contract For Trulicity Hinges On Head-To-Head Superiority

Jun 29 2016

Rx Cost Containment At CareFirst Driven By Physician Incentives

Jun 21 2016

Related Companies

Gilead Sciences, Inc.

Express Scripts Holding Company

Additional Topics

United States Policy Commercial Market Access BioPharmaceutical

More from United States

More from North America

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window